AraƱez, Rose E.
HRN: 25-24-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
CEFTRIAXONE 1G (VIAL)
07/02/2024
07/08/2024
IV
1gm
Q12
Fracture, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes